Clinic
Texas Heart Hospital of the Southwest LLC
Texas Heart Hospital of the Southwest LLC was paid $2K by Medicaid between Mar 2021 and Aug 2024, across 30 billing codes. Its largest line is 93306, Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete — 50% of everything it billed.
33Billing provider infoTEXAS HEART HOSPITAL OF THE SOUTHWEST LLC
DALLAS, TX 75226
DALLAS, TX 75226
33aNPI1609855139assigned 01/12/2006
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$2K
24GClaims5,085
24DCodes billed30
24AFirst – last monthMar 2021 – Aug 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Texas
Rank by total paid#248 of 320
Median peer was paid$205K
This provider vs. median0.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 2,447 | $628.70 | |
| 2022 | 1,458 | $791.86 | |
| 2023 | 953 | $106.86 | |
| 2024incomplete | 227 | $1.89 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 50% | 12 | 12 | $765.59 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 10% | 38 | 37 | $155.07 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 9.3% | 428 | 401 | $142.10 |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 7.4% | 234 | 225 | $112.96 |
| J1644 | Injection, heparin sodium, per 1000 units | 7.2% | 618 | 327 | $110.79 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 6.5% | 67 | 63 | $100.09 |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2.4% | 121 | 113 | $36.90 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1.6% | 37 | 36 | $23.75 |
| 82330 | 1.4% | 153 | 144 | $21.84 | |
| 82565 | <1% | 190 | 176 | $8.18 | |
| 84295 | <1% | 167 | 157 | $7.68 | |
| 84132 | <1% | 171 | 161 | $7.60 |
18 more codes
| 82435 | <1% | 165 | $7.34 | |
| 84520 | <1% | 165 | $6.30 | |
| 82947 | <1% | 168 | $6.28 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 20 | $6.20 |
| 85014 | <1% | 393 | $5.67 | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | <1% | 271 | $4.97 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 172 | $0.00 |
| 36415 | Collection of venous blood by venipuncture | 0% | 682 | $0.00 |
| 80047 | 0% | 260 | $0.00 | |
| J2704 | Injection, propofol, 10 mg | 0% | 86 | $0.00 |
| C1769 | Guide wire | 0% | 207 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 76 | $0.00 |
| C1725 | Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) | 0% | 27 | $0.00 |
| 85018 | 0% | 27 | $0.00 | |
| 82962 | 0% | 53 | $0.00 | |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 0% | 41 | $0.00 |
| 99152 | 0% | 24 | $0.00 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialVALENTINE, MARK (CEO)
| Provider | Location | Paid |
|---|---|---|
| Texas Heart Hospital of the Southwest, LLC | Plano, TX | $18K |
| THHBP Management Company LLC | Denton, TX | $128.95 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.